This result has biological support as HCV GT3a is known to be associated with lower LDL-C, hypobetalipoproteinemia, and increased liver steatosis due to viral-mediated inhibition of microsomal triglyceride transfer protein [5,6,7]. The gene discussed is MTTP; the disease is Hepatic steatosis.